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Case report
Transverse myelopathy and radiculomyelopathy
associated with pulmonary atypical Mycobacterium
infections
V L C White, R Al-Shahi, E Gamble, P Brown, A G Davison
Abstract
Myelopathy is a well recognised but rare
association withMycobacterium tubercu-
losis infection, but has not been described
with atypical mycobacteria.We report two
cases of disabling myelopathy in associ-
ation with pulmonary infection by Myco-
bacterium kansasii and Mycobacterium
malmoense; the myelopathy is presumed
to be a para-infectious phenomenon.
(Thorax 2001;56:158–160)
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Approximately 50 species within the genus
Mycobacterium exist naturally in the environ-
ment: they are variously called atypical myco-
bacteria, environmental mycobacteria, and
non-tuberculous mycobacteria. Opportunistic
pulmonary infection with atypical mycobacte-
ria may occur in immunocompetent individu-
als, especially with previously damaged lungs,
and disseminated infection is seen in immuno-
compromised hosts, especially with AIDS.1–3
Both Mycobacterium malmoense and Myco-
bacterium kansasii are environmental mycobac-
teria. The number of cases of opportunistic
mycobacteria has been rising in England and
Wales from 1982 to 1994.2 The incidence ofM
kansasii has, however, remained stable at
approximately 50 per year. The number of
cases of infection with M malmoense has risen
steadily from 1982 and is now approximately
50 per year.Mmalmoense does not appear to be
related to HIV.2
Myelopathy has not previously been re-
ported as a complication of environmental
mycobacterial infection and other neurological
complications are extremely rare.4
Case reports
CASE 1
A 23 year old, right handed computer operator
with type 1 diabetes mellitus presented with a
four month history of weight loss, productive
cough, increasing breathlessness, and a one day
history of chest pain. On examination the only
abnormalities were coarse inspiratory crackles
in both upper zones of the chest and some ten-
derness to the right of the T8 spinous process.
Routine biochemical and haematological in-
vestigations were normal. Chest radiography
showed multiple, bilateral, thin walled cavities
in the upper zones. Ziehl-Neilson staining of
the sputum confirmed the presence of acid and
alcohol fast bacilli. HIV antibody test was
negative. Treatment was started with ri-
fampicin, isoniazid, and pyrazinamide.
Figure 1 (A) Sagittal T1 weighted magnetic resonance image (MRI) of the cervical and thoracic cord of case 1
demonstrating focal enhancement at the level of T4. (B) Axial MR image of case 1 at the level of T4 showing focal cord
enhancement. (C) Sagittal T2 weighted MRI of the cervical and thoracic cord of case 1 revealing high signal within the
cord from T2 to T5.
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One month later he presented with a four
day history of leg weakness and was unable to
walk. He complained of electric shock-like
pains in the legs, a two day history of loss of
sensation below the umbilicus, and diYculty in
passing urine. Clinical examination of the
upper limbs was normal. There was lower limb
hypertonia with Medical Research Council
(MRC) grade 2–3/5 weakness in a pyramidal
distribution and extensor plantar responses.
There was a sensory level at T6. The cranial
nerves and higher function were normal. He
was in urinary retention.
Further investigations showed that autoanti-
body screen and syphilis serology were nega-
tive. Serum B12 levels were normal and the C
reactive protein (CRP) level was 80 mg/l.
Examination of the cerebrospinal fluid (CSF)
revealed a protein level of 0.76 g/l, glucose
8.4 mmol/l (serum glucose 8.3 mmol/l), white
cell count 5/mm3, and there were no oligo-
clonal bands in the CSF or serum. Gram stain
and bacterial culture of the CSF were negative
and there was no growth on Lowenstein-Jensen
medium at eight weeks. Magnetic resonance
imaging (MRI) of the spine showed high signal
involving the grey matter and posterior col-
umns at the level of T4 and no abnormalities in
the brain (fig 1).
A diagnosis of transverse myelitis was made
and the patient was treated with intravenous
methylprednisolone (500 mg) daily for three
days followed by an oral dose of 100 mg daily
which was gradually reduced over 18 weeks.
The original sputum cultures grewM kansasii.
The antituberculous regime was changed to
ethambutol and rifampicin.
Over the following months his respiratory
symptoms and chest radiograph gradually
improved. There was some recovery of power
in the lower limbs such that after six months he
was able to weight bear and transfer but
remained wheelchair dependent with an ind-
welling urinary catheter.
CASE 2
A 39 year old, left handed care assistant
presented with a 10 day history of pain radiat-
ing into the epigastrium associated with nausea
and vomiting. She smoked 15 cigarettes per
day and had had a non-productive cough for
two months without fever. Physical examina-
tion was unremarkable. Chest radiography
showed patchy consolidation at the right apex
and bronchoscopy was arranged as an out-
patient.
Within a week she was readmitted with
band-like thoracic pain associated with urinary
incontinence, paraesthesiae in the legs, and
worsening bilateral leg weakness such that she
was unable to walk. Examination of the arms
was normal but there was hypertonia of the legs
with MRC grade 4/5 weakness in a pyramidal
distribution, hyperreflexia, and extensor
plantar responses. There was a sensory level at
T4. The cranial nerves and higher function
were normal.
Routine biochemical and haematological
investigations were normal, as were immu-
noglobulins, autoantibodies, CRP, B12, syphi-
lis serology, and CD4/CD8 ratio. Examination
of the CSF revealed a protein level of 1.4 g/l,
white cell count of 26/mm3, glucose level of
2.9 mmol/l (serum glucose 5.9 mmol/l) with
negative Gram and Ziehl-Neilson stains and
there was no growth on Lowenstein-Jensen
medium at six weeks. The CSF initially showed
intrathecal synthesis of a solitary IgG clone but
during the illness she developed evidence of
intrathecal synthesis of several IgG clones.
Bone scan was normal. MRI showed increased
signal intensity in the lower cervical and upper
thoracic spinal cord and no abnormalities in
the brain on repeated examination over two
years.
A diagnosis of transverse myelitis was made
and the patient was treated with daily intra-
venous methylprednisolone (1 g) for three days
with some improvement in leg power. Bron-
choscopic lavage showed acid-fast bacilli and
the patient was started on antituberculous
medication. Subsequent culture of the lavage
fluid grew M malmoense and she was treated
with isoniazid, rifampicin, pyrazinamide,
ethambutol, and streptomycin.
There were three subsequent neurological
relapses over the next 14 months, the second of
which caused bilateral arm weakness and an
episode of acute respiratory failure requiring
six weeks’ mechanical ventilation. At this stage
signal changes within the cord on MRI
extended to the craniocervical junction and the
medulla oblongata with swelling and irregular
contrast enhancement. Each relapse was
treated with intravenous methylprednisolone
with mild improvement but residual disability.
Eighteen months after presentation she had
a spastic quadriparesis with MRC grade 2/5
Figure 2 Sagittal T1 weighted magnetic resonance image
(MRI) of case 2 10 weeks after presentation showing
atrophy of the cervical cord and probable myelomalacia of
the lower cervical and upper thoracic segments.
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weakness in a pyramidal pattern in the legs and
grade 4/5 weakness in the arms with superim-
posed, right-sided wasting and weakness of
trapezius, serratus anterior, infraspinatus, supi-
nator and small hand muscles. There was
evidence of action induced myoclonus of the
right fingers. She had a sensory level at C3 and
a forced vital capacity of 2.4 litres. Visual acui-
ties in both eyes were 6/6 with normal colour
vision and no evidence of aVerent pupillary
defects. Cranial nerves and higher cortical
function were normal. The cervical spinal cord
appeared atrophic on MRI, maximal at C3 (fig
2). She had abnormal somatosensory evoked
potentials and nerve conduction studies from
both upper limbs suggesting a lesion in the
large fibre sensory pathways at the level of the
preganglionic C6/7 dorsal roots. Visual evoked
potentials of both eyes were attenuated, but not
delayed, compatible with bilateral axonal optic
neuropathy. She has remained clinically stable
for 30 months.
Discussion
Transverse myelopathy has never been re-
ported in association with M malmoense nor M
kansasii although M tuberculosis is known to
cause a myelopathy by direct infection, arach-
noiditis, compression, and as a para-infectious
process in association with pulmonary
tuberculosis.5–7 Both M malmoense and M
kansasii are environmental pathogens, the
former being found in the soil and the latter in
water and is able to colonise piped water
supplies. They are also found as contaminants
in culture. They are recognised as pulmonary
pathogens, particularly in patients with previ-
ously damaged lungs.1 Healthy people may also
be aVected, more commonly in middle aged or
elderly individuals. They also cause disease in
lymph nodes, skin, gut and bursae.8 Dissemi-
nated infection is now seen in immunocompro-
mised hosts. Human to human spread is not
thought to occur.9 The recommended treat-
ment is with multiple antituberculous drugs
which for M malmoense includes ethambutol
and lasts 24 months; for M kansasii regimes
should include rifampicin and ethambutol for
nine months and isoniazid for three or nine
months.3 10
The first patient developed a transverse
myelitis some weeks after the initial pulmonary
infection was diagnosed and treatment started.
The second patient had a combination of a
relapsing myelopathy, radiculopathy, and a
subclinical optic neuropathy. The myelopathy
developed before antituberculous chemo-
therapy was commenced, although the optic
neuropathy may have developed subsequently.
Ethambutol is well known to cause retrobulbar
neuritis and isoniazid rarely causes optic
neuropathy; they may both cause a peripheral
neuropathy but myelopathy has not been
reported. It is assumed that these myelopathies
were para-infectious in origin in the absence of
evidence of active tuberculous infection of the
spinal cord or a direct relation to treatment.
In three cases of acute myelopathy associated
with pulmonary tuberculosis that have
undergone post-mortem examination5 the
myelopathy had been progressive or relapsing
(although only one patient received cortico-
steroids) and demyelination of the white and
grey matter was found in the spinal cord of all
three patients. Another similar case6 showed
clinical improvement after steroid therapy. In a
small series of patients with neuromyelitis
optica (myelopathy and optic neuropathy) and
pulmonary tuberculosis7 there was no visual
improvement; five of the eight patients showed
some degree of amelioration of the spinal cord
symptoms but the prognosis was worse than in
idiopathic transverse myelitis. The CSF find-
ings in all the reported cases were similar to
those of our two patients—increased protein
with a pleocytosis and occasionally a low
glucose level—the only consistent finding
being failure to isolateMycobacterium spp from
the CSF. The underlying mechanism for such
acute necrotic myelopathies is unclear but it
has been postulated that tuberculous infection
might amplify the body’s immune response to
myelin damage through an adjuvant eVect or
through shared epitopes on myelin basic
protein and tubercle bacillus.5 The initial
development of oligoclonal IgG in the CSF of
case 2 supports the hypothesis that tuberculous
infection triggers an intrathecal immune re-
sponse.
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